Molecular Partners AG Sponsored ADR MOLN

4.22 (0.08) (1.86%) as of 25 Sep
Market cap
$160.5M
P/E
0.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Cash and Short Term Investments
176.69 143.94 100.98 98.02 185.29 145.31 261.08 208.18 169.75 112.32
Receivables
0.83 1.18 52.67 2.13 3.03 28.06 1.07 2.18 2.63 2.21
Other current assets
0.48 0.32 2.80 2.86 1.65 6.24 4.81 4.03 2.87 2.40
Total current assets
178.00 145.43 156.45 103.01 189.65 179.64 266.95 214.38 175.25 116.93
Property, Plant, Equpment (Net)
2.45 1.91 1.48 4.37 10.01 8.91 7.58 6.33 4.77 6.31
Goodwill and Intangible Assets (Total)
0.05 0.03 0.39 0.80 0.37 0.36 0.28 0.24 0.06 0.00
Total non-current assets
— — — — 10.38 9.27 7.87 6.56 4.82 6.31
Total Assets
180.49 0.00 158.32 108.18 200.04 188.92 274.82 220.94 180.07 123.24
Accounts Payable
1.01 0.73 2.15 2.08 6.21 8.08 2.25 1.48 2.11 2.13
Accrued Expenses
— — — — 8.23 10.91 7.86 8.41 8.76 9.72
Current Part of Debt
— — — 1.31 — — — — — —
Current Part of Capital Lease
— — — — 1.26 1.30 1.26 1.35 1.38 1.46
Other current liabilities
14.45 13.70 35.47 26.10 45.81 30.98 6.72 4.83 — —
Total current liabilities
15.46 14.43 37.62 29.49 61.51 51.28 18.08 16.06 12.25 13.31
Long Term Debt (Total)
— — — 1.32 — — — — — —
Non-current Revenue (Deferred)
26.29 9.73 21.30 10.33 — — — — — —
Pension and Post-Retirement Liabilities
— — — — 14.59 7.37 2.67 5.64 5.54 9.83
Non-current Liabilities (Other)
5.61 4.10 5.83 11.23 3.13 7.58 3.81 — — 0.19
Total non-current liabilities
— — — — 24.16 20.26 10.31 8.36 6.94 12.97
Total liabilities
47.36 28.26 64.75 52.37 85.68 71.53 28.39 24.42 19.19 26.28
Additional Paid In Capital
— — — — 319.42 388.42 377.58 407.16 437.18 469.74
Common Stock (Net)
2.03 2.15 2.17 2.23 3.11 3.53 3.78 4.05 4.58 4.87
Retained Earnings
(36.53) (61.96) (91.69) (134.92) (208.17) (274.56) (133.90) (213.60) (279.76) (376.29)
Treasury Stock
— — — — — — 1.03 1.09 1.11 1.36
Common Equity (Total)
133.13 119.11 93.58 55.81 114.36 117.38 246.43 196.52 160.89 96.96
Shareholders Equity (Total)
133.13 119.11 93.58 55.81 114.36 117.38 246.43 196.52 160.89 96.96
Shareholders Equity and Liabilities (Total)
— — — — 200.04 188.92 274.82 220.94 180.07 123.24
Shares (Common)
— — — — 32.16 32.29 36.05 36.35 40.36 40.38
Shareholders Equity (Tangible)
— — — — 113.99 117.02 246.15 196.29 160.83 96.96
Net Debt
(176.69) (143.94) (100.98) (95.40) (185.29) (145.31) (261.08) (208.18) (169.75) (112.32)
Total Debt
— — — 2.62 8.20 6.64 5.27 — — —

Fold the line items

In millions of $ except per-share values · columns are period end dates